| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |